Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2875

1.

Radiologic Assessment for Endoscopic US-guided Biliary Drainage.

Sugawara S, Sone M, Morita S, Hijioka S, Sakamoto Y, Kusumoto M, Arai Y.

Radiographics. 2020 Mar 27:190158. doi: 10.1148/rg.2020190158. [Epub ahead of print]

PMID:
32216704
2.

Analysis of semicircular canal function as evaluated by video Head Impulse Test in patients with vestibular schwannoma.

Fujiwara K, Morita S, Fukuda A, Akamatsu H, Yanagi H, Hoshino K, Nakamaru Y, Kano S, Homma A.

J Vestib Res. 2020 Mar 18. doi: 10.3233/VES-200695. [Epub ahead of print]

PMID:
32200369
3.

Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.

Hanzawa N, Hashimoto K, Yuan X, Kawahori K, Tsujimoto K, Hamaguchi M, Tanaka T, Nagaoka Y, Nishina H, Morita S, Hatada I, Yamada T, Ogawa Y.

Sci Rep. 2020 Mar 20;10(1):5181. doi: 10.1038/s41598-020-62035-6.

4.

Humeral bone resorption after reverse shoulder arthroplasty using uncemented stem.

Inoue K, Suenaga N, Oizumi N, Yamaguchi H, Miyoshi N, Taniguchi N, Morita S, Munemoto M, Kurata S, Tanaka Y.

JSES Int. 2020 Jan 14;4(1):138-143. doi: 10.1016/j.jses.2019.11.007. eCollection 2020 Mar.

5.

Repression of G1/S Transition by Transient Inhibition of miR-10404 Expression in Drosophila Primordial Germ Cells.

Morita S, Ota R, Hayashi M, Kobayashi S.

iScience. 2020 Feb 28;23(3):100950. doi: 10.1016/j.isci.2020.100950. [Epub ahead of print]

6.

Analysis of anatomical variations of intrapelvic vessels for advanced pelvic surgery.

Hamabe A, Harino T, Ogino T, Tanida T, Noura S, Morita S, Dono K.

BMC Surg. 2020 Mar 16;20(1):47. doi: 10.1186/s12893-020-00711-0.

7.

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.

Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko K, Fujisawa T, Takahashi M, Kadoya T, Matsunami N, Yamamoto Y, Ohno S, Takano T, Morita S, Tanaka-Mizuno S, Toi M.

Breast Cancer Res Treat. 2020 Mar 13. doi: 10.1007/s10549-020-05590-w. [Epub ahead of print]

PMID:
32170634
8.

[The Current Status of Palliative Care for Cancer on a Questionnaire Survey].

Sawami H, Hiraki M, Sawada G, Murakami M, Suzuki R, Fukunaga H, Morita S.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2273-2275. Japanese.

PMID:
32156902
9.

[A Case of Successful Surgical Treatment for Paraaortic Lymph Nodes Recurrence of Gallbladder Cancer].

Urahigashi A, Fukunaga H, Sawami H, Hiraki M, Sawada G, Murakami M, Chihara Y, Yamamoto M, Kimura H, Morita S.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2261-2263. Japanese.

PMID:
32156898
10.

Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss.

Oka SI, Day TF, Nishio SY, Moteki H, Miyagawa M, Morita S, Izumi S, Ikezono T, Abe S, Nakayama J, Hyogo M, Okamoto N, Uehara N, Oshikawa C, Kitajiri SI, Usami SI.

Genes (Basel). 2020 Mar 4;11(3). pii: E273. doi: 10.3390/genes11030273.

11.

Safety and efficacy of plasma exchange via direct femoral vein puncture in autoimmune blistering diseases.

Yoshida T, Minakuchi H, Takahashi R, Morita S, Oya M.

J Clin Apher. 2020 Mar 6. doi: 10.1002/jca.21774. [Epub ahead of print]

PMID:
32142168
12.

Dietary arachidonic acid improves age-related excessive enhancement of the stress response.

Sueyasu T, Morita S, Tokuda H, Kaneda Y, Rogi T, Shibata H.

Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2110-2119. doi: 10.26355/eurrev_202002_20391.

PMID:
32141581
13.

Stress Responses of Shade-Treated Tea Leaves to High Light Exposure after Removal of Shading.

Sano S, Takemoto T, Ogihara A, Suzuki K, Masumura T, Satoh S, Takano K, Mimura Y, Morita S.

Plants (Basel). 2020 Mar 1;9(3). pii: E302. doi: 10.3390/plants9030302.

14.

Practical Computation of FFT based Generalized Two-Dimensional Correlation Spectroscopy.

He M, Miyata D, Nakabayashi T, Morita SI.

Anal Sci. 2020 Feb 28. doi: 10.2116/analsci.20N005. [Epub ahead of print] No abstract available.

15.

Evaluation of Protein Requirements Using the Indicator Amino Acid Oxidation Method.

Yoshikawa M, Morita S, Sonoki H, Iwamoto H, Takeda Y.

J Nutr Sci Vitaminol (Tokyo). 2020;66(1):54-59. doi: 10.3177/jnsv.66.54.

16.

Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform.

Morita S, Horii T, Kimura M, Hatada I.

Int J Mol Sci. 2020 Feb 25;21(5). pii: E1574. doi: 10.3390/ijms21051574.

17.

Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.

Watabe S, Kikuchi Y, Morita S, Komura D, Numakura S, Kumagai-Togashi A, Watanabe M, Matsutani N, Kawamura M, Yasuda M, Uozaki H.

Cancer Med. 2020 Feb 24. doi: 10.1002/cam4.2928. [Epub ahead of print]

18.

Resting-state EEG beta band power predicts quality of life outcomes in patients with depressive disorders: A longitudinal investigation.

Koshiyama D, Kirihara K, Usui K, Tada M, Fujioka M, Morita S, Kawakami S, Yamagishi M, Sakurada H, Sakakibara E, Satomura Y, Okada N, Kondo S, Araki T, Jinde S, Kasai K.

J Affect Disord. 2020 Mar 15;265:416-422. doi: 10.1016/j.jad.2020.01.030. Epub 2020 Jan 10.

PMID:
32090768
19.

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.

Kurimoto C, Inaba H, Ariyasu H, Iwakura H, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Morita S, Yamamoto Y, Yamashita S, Katsuda M, Hayata A, Akamatsu H, Jinnin M, Hara I, Yamaue H, Akamizu T.

Cancer Sci. 2020 Feb 22. doi: 10.1111/cas.14363. [Epub ahead of print]

20.

Evaluation of Semicircular Canal Function by Video Head Impulse Test in Patients With Facial Nerve Schwannoma.

Fujiwara K, Morita S, Furuta Y, Yanagi H, Hoshino K, Fukuda A, Nakamaru Y, Homma A.

Otol Neurotol. 2020 Feb 19. doi: 10.1097/MAO.0000000000002591. [Epub ahead of print]

PMID:
32080027
21.

Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271.

Morita S, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Yamazaki T, Imai T, Asada Y, Matsuura K, Kawamura S, Yamaguchi K, Yasuda J, Sugamura K, Katori Y, Satoh K, Tamai K.

Monoclon Antib Immunodiagn Immunother. 2020 Feb;39(1):6-11. doi: 10.1089/mab.2019.0040.

PMID:
32069133
22.

Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma.

Takamatsu K, Takeda T, Hattori S, Tanaka N, Morita S, Matsumoto K, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Kurihara I, Itoh H, Oya M.

Clin Endocrinol (Oxf). 2020 Feb 18. doi: 10.1111/cen.14176. [Epub ahead of print]

PMID:
32068902
23.

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group.

Breast Cancer. 2020 Feb 14. doi: 10.1007/s12282-020-01057-4. [Epub ahead of print]

PMID:
32060785
24.

Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.

Ikeda HO, Muraoka Y, Hata M, Sumi E, Ikeda T, Nakagawa T, Abe H, Tada H, Morita S, Kakizuka A, Yoshimura N, Tsujikawa A.

PLoS One. 2020 Feb 13;15(2):e0229068. doi: 10.1371/journal.pone.0229068. eCollection 2020.

25.

Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis.

Murakami I, Murakami K, Hashimoto M, Tanaka M, Ito H, Fujii T, Torii M, Ikeda K, Kuwabara A, Tanaka K, Yoshida A, Akizuki S, Nakashima R, Yoshifuji H, Ohmura K, Usui T, Morita S, Mimori T.

PLoS One. 2020 Feb 13;15(2):e0228852. doi: 10.1371/journal.pone.0228852. eCollection 2020.

26.

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Hattori Y, Kono Y, Itoh S, Inoue T, Urata Y, Kawa Y, Tohnai R, Kumagai T, Nishino K, Uozumi R, Morita S, Negoro S, Imamura F, Satouchi M.

BMC Cancer. 2020 Feb 11;20(1):115. doi: 10.1186/s12885-020-6588-y.

27.

Protocols for Enzymatic Fluorometric Assays to Quantify Phospholipid Classes.

Morita SY, Tsuji T, Terada T.

Int J Mol Sci. 2020 Feb 4;21(3). pii: E1032. doi: 10.3390/ijms21031032. Review.

28.

Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report.

Shinoda K, Morita S, Tamaki S, Takahashi R, Kitaoka S, Asanuma H, Yoshida T, Okayama M, Kasahara H, Okamoto S, Oya M.

Transplant Proc. 2020 Mar;52(2):604-607. doi: 10.1016/j.transproceed.2019.10.035. Epub 2020 Feb 3.

PMID:
32029318
29.

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.

Tokudome N, Koh Y, Akamatsu H, Fujimoto D, Okamoto I, Nakagawa K, Hida T, Imamura F, Morita S, Yamamoto N.

BMC Cancer. 2020 Feb 6;20(1):103. doi: 10.1186/s12885-020-6593-1.

30.

Head and Neck Paraganglioma Atypically Carrying a Succinate Dehydrogenase Subunit B Mutation (L157X).

Takeshima K, Ariyasu H, Uraki S, Kitahara C, Morita S, Inaba H, Iwakura H, Warigaya K, Murata SI, Yamazaki Y, Sasano H, Akamizu T.

Intern Med. 2020 Feb 5. doi: 10.2169/internalmedicine.3607-19. [Epub ahead of print]

31.

Elucidation of the Effects of a Current X-SCID Therapy on Intestinal Lymphoid Organogenesis Using an In Vivo Animal Model.

Nochi T, Suzuki S, Ito S, Morita S, Furukawa M, Fuchimoto D, Sasahara Y, Usami K, Niimi K, Itano O, Kitago M, Matsuda S, Matsuo A, Suyama Y, Sakai Y, Wu G, Bazer FW, Watanabe K, Onishi A, Aso H.

Cell Mol Gastroenterol Hepatol. 2020 Feb 1. pii: S2352-345X(20)30018-7. doi: 10.1016/j.jcmgh.2020.01.011. [Epub ahead of print]

32.

Image quality of early postoperative CT angiography with reduced contrast material and radiation dose using model-based iterative reconstruction for screening of renal pseudoaneurysms after partial nephrectomy.

Morita S, Ogawa Y, Yamamoto T, Kamoshida K, Yamazaki H, Suzuki K, Sakai S, Kunihara M, Takagi T, Tanabe K.

Eur J Radiol. 2020 Mar;124:108853. doi: 10.1016/j.ejrad.2020.108853. Epub 2020 Jan 28.

PMID:
32007820
33.

Osborn Wave Is Related to Ventricular Fibrillation and Tachycardia in Hypothermic Patients.

Okada N, Matsuyama T, Morita S, Ehara N, Miyamae N, Okada Y, Jo T, Sumida Y, Watanabe M, Nozawa M, Tsuruoka A, Fujimoto Y, Okumura Y, Hamanaka K, Kitamura T, Nishiyama K, Ohta B.

Circ J. 2020 Feb 25;84(3):445-455. doi: 10.1253/circj.CJ-19-0856. Epub 2020 Jan 30.

34.

Optimal Decision Criteria for the Study Design and Sample Size of a Biomarker-Driven Phase III Trial.

Takazawa A, Morita S.

Ther Innov Regul Sci. 2020 Jan 27. doi: 10.1007/s43441-020-00119-1. [Epub ahead of print]

PMID:
31989540
35.

Percutaneous Gastrojejunostomy Catheter Placement Using a Slow-Leak Balloon through the Reconstructed Gastric Tube after Esophagectomy.

Morita S, Arai Y, Sugawara S, Sone M, Tomita K, Ishii H, Terai S.

J Vasc Interv Radiol. 2020 Mar;31(3):478-481. doi: 10.1016/j.jvir.2019.09.009. Epub 2020 Jan 22.

PMID:
31982314
36.

Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

Ooki A, Morita S, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2020 Mar;9(5):1779-1789. doi: 10.1002/cam4.2826. Epub 2020 Jan 21.

37.

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.

Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takasuka T, Sakurai T, Kataoka TR, Morita S, Ohno S, Toi M.

Breast Cancer Res Treat. 2020 Feb;180(1):135-146. doi: 10.1007/s10549-020-05524-6. Epub 2020 Jan 17.

38.
39.

Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.

Morino K, Seo S, Yoh T, Fukumitsu K, Ishii T, Taura K, Morita S, Kaido T, Uemoto S.

Ann Surg Oncol. 2020 Jan 14. doi: 10.1245/s10434-020-08207-0. [Epub ahead of print]

PMID:
31939034
40.

Nicotinic acetylcholine receptor signaling regulates inositol-requiring enzyme 1α activation to protect β-cells against terminal unfolded protein response under irremediable endoplasmic reticulum stress.

Ishibashi T, Morita S, Kishimoto S, Uraki S, Takeshima K, Furukawa Y, Inaba H, Ariyasu H, Iwakura H, Furuta H, Nishi M, Papa FR, Akamizu T.

J Diabetes Investig. 2020 Jan 10. doi: 10.1111/jdi.13211. [Epub ahead of print]

41.

A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery.

Ito H, Nakayama H, Yokose T, Nagashima T, Morohoshi T, Tajiri M, Maehara T, Watanabe K, Arai H, Yamamoto T, Woo T, Nishii T, Ishikawa Y, Morita S, Masuda M.

Jpn J Clin Oncol. 2020 Feb 17;50(2):198-205. doi: 10.1093/jjco/hyz164.

PMID:
31917421
42.

S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial.

Sunami E, Kusumoto T, Ota M, Sakamoto Y, Yoshida K, Tomita N, Maeda A, Teshima J, Okabe M, Tanaka C, Yamauchi J, Itabashi M, Kotake K, Takahashi K, Baba H, Boku N, Aiba K, Ishiguro M, Morita S, Takenaka N, Okude R, Sugihara K.

Clin Colorectal Cancer. 2020 Mar;19(1):22-31.e6. doi: 10.1016/j.clcc.2019.10.002. Epub 2019 Oct 18.

43.

DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.

Watanabe H, Higashimoto K, Miyake N, Morita S, Horii T, Kimura M, Suzuki T, Maeda T, Hidaka H, Aoki S, Yatsuki H, Okamoto N, Uemura T, Hatada I, Matsumoto N, Soejima H.

FASEB J. 2020 Jan;34(1):960-973. doi: 10.1096/fj.201901757R. Epub 2019 Nov 28.

44.

Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature.

Morita S, Kamimura K, Abe H, Watanabe-Mori Y, Oda C, Kobayashi T, Arao Y, Tani Y, Ohashi R, Ajioka Y, Terai S.

World J Gastroenterol. 2019 Dec 28;25(48):6949-6958. doi: 10.3748/wjg.v25.i48.6949.

45.

Correction to: Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.

Tsutsumi I, Kunisawa S, Yoshida C, Seki M, Komeno T, Fushimi K, Morita S, Imanaka Y.

Int J Clin Oncol. 2020 Jan 6. doi: 10.1007/s10147-019-01601-z. [Epub ahead of print]

PMID:
31907718
46.

The localization of rice prolamin species in protein body type I is determined by the temporal control of gene expression of the respective prolamin promoters.

Sasou A, Shigemitsu T, Morita S, Masumura T.

Plant Biotechnol (Tokyo). 2018 Dec 25;35(4):405-409. doi: 10.5511/plantbiotechnology.18.0918a.

47.

Lipid class composition of membrane and raft fractions from brains of individuals with Alzheimer's disease.

Kawatsuki A, Morita SY, Watanabe N, Hibino E, Mitsuishi Y, Sugi T, Murayama S, Nishimura M.

Biochem Biophys Rep. 2019 Nov 4;20:100704. doi: 10.1016/j.bbrep.2019.100704. eCollection 2019 Dec.

48.

Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma.

Banno T, Takagi T, Kondo T, Yoshida K, Iizuka J, Okumi M, Ishida H, Morita S, Nagashima Y, Tanabe K.

Int Braz J Urol. 2020 Jan-Feb;46(1):26-33. doi: 10.1590/S1677-5538.IBJU.2018.0716.

49.

Primary aldosteronism in Klinefelter's syndrome: two cases.

Seki Y, Morimoto S, Yoshida N, Bokuda K, Sasaki N, Yatabe M, Yatabe J, Watanabe D, Morita S, Hata K, Yamamoto T, Nagashima Y, Ichihara A.

Endocrinol Diabetes Metab Case Rep. 2019 Dec 16;2019. pii: EDM190126. doi: 10.1530/EDM-19-0126. [Epub ahead of print]

50.

Administration timing and duration-dependent effects of sesamin isomers on lipid metabolism in rats.

Tateishi N, Morita S, Yamazaki I, Okumura H, Kominami M, Akazawa S, Funaki A, Tomimori N, Rogi T, Shibata H, Shibata S.

Chronobiol Int. 2019 Dec 13:1-17. doi: 10.1080/07420528.2019.1700998. [Epub ahead of print]

PMID:
31833423

Supplemental Content

Loading ...
Support Center